News
The U.S. will raise tariffs on scores of nations, effective at 12:01 a.m. on Aug. 7, according to an executive order Trump signed on Thursday. When the action is taken, the result will be ...
Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...
As you might know, GSK plc (LON:GSK) recently reported its interim numbers. GSK reported UK£16b in revenue, roughly in line ...
The FTSE 100 has continued to notch fresh highs, as UK stocks have been swept in broader market optimism around developments on US tariffs.
1d
Zacks Investment Research on MSNGSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise
GSK plc GSK reported second-quarter 2025 core earnings of $1.23 per American depositary share (ADS), which beat the Zacks ...
GSK tops Q2 estimates with growth in vaccines and specialty drugs, raises 2025 forecast amid progress in major late-stage ...
British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, despite US tariffs, after sales of its cancer drugs jumped in the second quarter ...
GSK lifted profit guidance for the year on Wednesday after sales of the drugmaker's 'specialty' medicines soared.
(Alliance News) - GSK predicted an annual outturn at the top end of guidance, BAE Systems maintained its outlook, while Aston Martin softened its profit forecast. Here is what you need to know before ...
Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...
Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...
In May, biotech iTeos Therapeutics decided to close down after being abandoned by GSK over the disappointing mid-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results